These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 18767002

  • 1. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A.
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C, Doria R, Leonildi A, Martinelli C, Menichetti F.
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [Abstract] [Full Text] [Related]

  • 4. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N, Akduman D, Aydemir H, Celebi G, Oztoprak N, Aktaş E.
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [Abstract] [Full Text] [Related]

  • 5. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV, Lopez-Cortes LE, Luque-Marquez R, Galvez-Acebal J, de Alarcon-Gonzalez A.
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [Abstract] [Full Text] [Related]

  • 6. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A.
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [Abstract] [Full Text] [Related]

  • 7. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM, Hospital Clinic Endocarditis Study Group.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1714-1722. PubMed ID: 28204495
    [Abstract] [Full Text] [Related]

  • 8. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Castañeda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM, Hospital Clinic Endocarditis Study Group.
    Clin Microbiol Infect; 2014 Dec 01; 20(12):O1075-83. PubMed ID: 25040215
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V, Donabedian SM, Zervos MJ, Kariyama R, Kumon H, Chow JW.
    Antimicrob Agents Chemother; 2000 Sep 01; 44(9):2545-6. PubMed ID: 10952613
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ.
    J Antimicrob Chemother; 2014 Aug 01; 69(8):2148-54. PubMed ID: 24777900
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A.
    Antimicrob Agents Chemother; 1999 Mar 01; 43(3):639-46. PubMed ID: 10049280
    [Abstract] [Full Text] [Related]

  • 12. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L, Klinger-Strobel M, Hartung A, Stein C, Makarewicz O, Pletz MW.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1553-1561. PubMed ID: 29506271
    [Abstract] [Full Text] [Related]

  • 13. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
    Antony SJ, Ladner J, Stratton CW, Raudales F, Dummer SJ.
    Scand J Infect Dis; 1997 Jun 01; 29(6):628-30. PubMed ID: 9571747
    [Abstract] [Full Text] [Related]

  • 14. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis.
    Luque-Paz D, Cuervo G, Miró JM, Tattevin P.
    Clin Microbiol Infect; 2023 Jun 01; 29(6):676-678. PubMed ID: 36889644
    [No Abstract] [Full Text] [Related]

  • 15. Enterococcal endocarditis revisited.
    Pericás JM, Zboromyrska Y, Cervera C, Castañeda X, Almela M, Garcia-de-la-Maria C, Mestres C, Falces C, Quintana E, Ninot S, Llopis J, Marco F, Moreno A, Miró JM.
    Future Microbiol; 2015 Jun 01; 10(7):1215-40. PubMed ID: 26118390
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.
    Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F, Italian Infective Endocarditis Study Group (SEI).
    Chemotherapy; 2011 Jun 01; 57(5):426-33. PubMed ID: 22122863
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
    Sierra-Hoffman M, Iznaola O, Goodwin M, Mohr J.
    Antimicrob Agents Chemother; 2012 Nov 01; 56(11):6064. PubMed ID: 22964255
    [No Abstract] [Full Text] [Related]

  • 18. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    Westbrook KJ, Chilambi GS, Stellfox ME, Nordstrom HR, Li Y, Iovleva A, Shah NH, Jones CE, Kline EG, Squires KM, Miller WR, Tran TT, Arias CA, Doi Y, Shields RK, Van Tyne D.
    J Antimicrob Chemother; 2024 Apr 02; 79(4):801-809. PubMed ID: 38334390
    [Abstract] [Full Text] [Related]

  • 19. Infective endocarditis caused by Enterococcus faecalis treated with continuous infusion of ampicillin without adjunctive aminoglycosides.
    Ogawa T, Sato M, Yonekawa S, Nakagawa C, Uno K, Kasahara K, Maeda K, Konishi M, Mikasa K.
    Intern Med; 2013 Apr 02; 52(10):1131-5. PubMed ID: 23676604
    [Abstract] [Full Text] [Related]

  • 20. Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis.
    Berdal JE, Eskesen A.
    Scand J Infect Dis; 2008 Apr 02; 40(9):765-6. PubMed ID: 18609208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.